MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-GJ-14-0009048
Umavida Pharma Private Limited - pharma in Kadi, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹24.5 Cr
▲ 52% YoY
Net loss · FY 2025
₹99.47 Lakh
Net margin -4.1%
EBITDA · FY 2025
₹3.82 Cr
EBITDA margin 15.6%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹40 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
70
Provident fund records
About Umavida Pharma Private Limited
Data last updated:
Umavida Pharma Private Limited is a private limited company based in Kadi, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24299GJ2019PTC107172. Its GSTIN is 24AACCU4028K1ZD (Gujarat).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Jagdishbhai Bhagwatbhai Desai and Fenil Jitendrakumar Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Survey No. – 396 Opp. Knack Packaging, Kadi – Thol Road Borisna, Gujarat, India – 382715.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.5 Cr, a growth of 52% compared to the previous year. For the same year it recorded a net loss of ₹99.47 Lakh (net margin -4.1%) and EBITDA of ₹3.82 Cr (EBITDA margin 15.6%).
The company has about 70 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹40 Cr on record.
Umavida Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-14-0009048). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website umavidapharma.com.
Company details
CIN U24299GJ2019PTC107172
Registration Number 107172
Incorporation Date 20 March 2019
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-GJ-14-0009048
Key People
Jagdishbhai Bhagwatbhai Desai Director Fenil Jitendrakumar Shah Director Bindiya Rakesh Gohel Director Recognitions & Rankings of Umavida Pharma
Contact details
Umavida Pharma Private Limited's registered office is in Kadi, Gujarat. Its website is umavidapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSurvey No. – 396 Opp. Knack Packaging, Kadi – Thol Road Borisna, Gujarat, India – 382715
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Umavida Pharma Private Limited, buy the company report.
Comprehensive company report
Umavida Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Umavida Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Umavida Pharma Private Limited, buy the company report.
Financials of Umavida Pharma Private Limited
FY 2025 filings availableUmavida Pharma Private Limited reported revenue of ₹24.5 Cr (up 52% YoY) for FY 2025.
Revenue · FY 2025
₹24.5 Cr ▲ 52%
Net loss · FY 2025
₹99.47 Lakh margin -4.1%
EBITDA · FY 2025
₹3.82 Cr margin 15.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 52%
EBITDA CAGR growth
1 year
▲ 230%
3 years · compounded
▲ 540%
5 years · compounded
▲ 163%
Revenue rose 52% in the latest year. EBITDA rose 230% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.82 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹99.47 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.6% | ||||
| Net Profit Margin | -4.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Umavida Pharma Private Limited, buy the company report.
Board of directors of Umavida Pharma Private Limited
Umavida Pharma has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagdishbhai Bhagwatbhai Desai | Director | 20 Mar 2019 | 7 Years 7 Months | Current |
| Fenil Jitendrakumar Shah Also directs: Nibin Pharmaceuticals Private Limited | Director | 20 Mar 2019 | 7 Years 7 Months | Current |
| Bindiya Rakesh Gohel | Director | 03 Aug 2022 | 4 Years 2 Months | Current |
| Shil Jitendra Shah Also directs: Nibin Pharmaceuticals Private Limited | Director | 20 Mar 2019 | 7 Years 7 Months | Current |
| Varun Hasmukh Patel Also directs: Jay Pumps Private Limited, Jay Water Management Private Limited, Blossom Sports and Recreation Club Ltd and 1 more | Director | 20 Mar 2019 | 7 Years 7 Months | Current |
| Vipul Raghunath Chaudhari | Director | 20 Mar 2019 | 7 Years 7 Months | Current |
Peer comparison
Umavida Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Remidex Pharma Private Limited | ₹24.56 Cr (FY 2025) | -22.0% | Bengaluru, Karnataka, India | |||
| De Dietrich India Private Limited | ₹24.55 Cr (FY 2025) | 23.0% | Navi Mumbai, Maharashtra, India | |||
| Stivaph Healthcare Private Limited | ₹24.54 Cr (FY 2025) | 112.0% | Ahmedabad, Gujarat, India | |||
| Vego & Thomson India Private Limited | ₹24.53 Cr (FY 2025) | -53.0% | New Delhi, Delhi, India | |||
| Sesha Sai Chemicals Private Limited | ₹24.51 Cr (FY 2025) | -36.0% | Telangana, India | |||
| Umavida Pharma Private Limitedthis company | ₹24.5 Cr (FY 2025) | -₹99.47 Lakh | -4.1% | 52.0% | 70 | Kadi, Gujarat, India |
| Carewell Steuart Pharma Private Limited | ₹24.5 Cr (FY 2025) | 79.0% | Tiruvallur, Tamil Nadu, India | |||
| MRHM Pharma Private Limited | ₹24.46 Cr (FY 2024) | 10.0% | Bangalore, Karnataka, India | |||
| Divyashakti Seeds Private Limited | ₹24.45 Cr (FY 2025) | 30.0% | Gandhinagar, Gujarat, India | |||
| Tanisha Resins Private Limited | ₹24.45 Cr (FY 2025) | -1.0% | Nagpur, Maharashtra, India | |||
| Sunberg Life Sciences Private Limited | ₹24.43 Cr (FY 2025) | 92.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Umavida Pharma Private Limited, buy the company report.
Auditor
Umavida Pharma Private Limited is audited by AMBALAL PATEL & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMBALAL PATEL & CO. | FY 2023 | 100305W |
Shareholding
The shareholding of Umavida Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Umavida Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹40 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Feb 2022 | 100544079 | Hdfc Bank Limited | ₹20 Cr | Open | |
| 04 Feb 2022 | 100545053 | Hdfc Bank Limited | ₹20 Cr | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Umavida Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Umavida Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Umavida Pharma Private Limited has a workforce of 70 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
70
Active EPFO establishments
1
Employee growth
40%
GST
Umavida Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCU4028K1ZD | Gujarat | Active | 11 Dec 2020 |
To see the full GST registrations and return filing status of Umavida Pharma Private Limited, buy the company report.
Recent activity
Umavida Pharma Private Limited has 8 board changes on record since 2019: 6 appointments and 2 cessations. The latest: Bindiya Rakesh Gohel ceased to be Additional Director on 30 Sep 2022.
AGM
Umavida Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Umavida Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Bindiya Rakesh Gohel ceased to be Additional Director.
Appointed
Bindiya Rakesh Gohel was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2,000.00 Lakh with Charge ID 100544079 was registered on 17 Feb 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2,000.00 Lakh with Charge ID 100545053 was registered on 04 Feb 2022.
Ceased
Aziz Fidaali Rahemani ceased to be Additional Director.
Appointed
Fenil Jitendrakumar Shah was appointed as Director.
Appointed
Jagdishbhai Bhagwatbhai Desai was appointed as Director.
Appointed
Shil Jitendra Shah was appointed as Director.
Appointed
Varun Hasmukh Patel was appointed as Director.
Appointed
Vipul Raghunath Chaudhari was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Umavida Pharma is an active private limited company based in Kadi, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 March 2019 (7+ years old) and is registered under CIN U24299GJ2019PTC107172.
Umavida Pharma has 6 current directors:
- Jagdishbhai Bhagwatbhai Desai - Director
- Fenil Jitendrakumar Shah - Director
- Bindiya Rakesh Gohel - Director
- Shil Jitendra Shah - Director
- Varun Hasmukh Patel - Director
- Vipul Raghunath Chaudhari - Director
The latest financial statements of Umavida Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Umavida Pharma is 24AACCU4028K1ZD, registered in Gujarat.
The CIN (Corporate Identification Number) of Umavida Pharma is U24299GJ2019PTC107172. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Umavida Pharma was incorporated on 20 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Umavida Pharma by revenue are Remidex Pharma Private Limited, De Dietrich India Private Limited, Stivaph Healthcare Private Limited, Vego & Thomson India Private Limited, Sesha Sai Chemicals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bindiya Rakesh Gohel ceased to be Additional Director on 30 Sep 2022. Bindiya Rakesh Gohel was appointed as Director on 03 Aug 2022. Aziz Fidaali Rahemani ceased to be Additional Director on 30 Sep 2020. Umavida Pharma has 8 board changes on record in total.
Yes, Umavida Pharma is registered as an MSME under Udyam registration (number: UDYAM-GJ-14-0009048).
Umavida Pharma can be reached through the website umavidapharma.com. Its registered office is in Kadi, Gujarat, India.
The registered office of Umavida Pharma is at Survey No. – 396 Opp. Knack Packaging, Kadi – Thol Road Borisna, Gujarat, India – 382715.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages